Cargando…

Metagenomic Next-Generation Sequencing for the Diagnosis of Pneumocystis jirovecii Pneumonia in Non-HIV-Infected Patients: A Retrospective Study

INTRODUCTION: This study aimed to evaluate the utility of metagenomic next-generation sequencing (mNGS) for the diagnosis of Pneumocystis jirovecii pneumonia (PJP) in non-human immunodeficiency virus-infected patients. METHODS: We conducted a retrospective study. A total of 60 non-human immunodefici...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Juan, Bai, Lu, Yang, Wei, Peng, Wenzhong, An, Jian, Wu, Yanhao, Pan, Pinhua, Li, Yuanyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322252/
https://www.ncbi.nlm.nih.gov/pubmed/34244957
http://dx.doi.org/10.1007/s40121-021-00482-y
_version_ 1783731013014257664
author Jiang, Juan
Bai, Lu
Yang, Wei
Peng, Wenzhong
An, Jian
Wu, Yanhao
Pan, Pinhua
Li, Yuanyuan
author_facet Jiang, Juan
Bai, Lu
Yang, Wei
Peng, Wenzhong
An, Jian
Wu, Yanhao
Pan, Pinhua
Li, Yuanyuan
author_sort Jiang, Juan
collection PubMed
description INTRODUCTION: This study aimed to evaluate the utility of metagenomic next-generation sequencing (mNGS) for the diagnosis of Pneumocystis jirovecii pneumonia (PJP) in non-human immunodeficiency virus-infected patients. METHODS: We conducted a retrospective study. A total of 60 non-human immunodeficiency virus-infected PJP patients and 134 patients diagnosed with non-PJP pneumonia were included. P. jirovecii and other co-pathogens identified by mNGS in bronchoalveolar lavage fluid and/or blood samples were analyzed. Using clinical composite diagnosis as the reference standard, we compared the diagnostic performance of mNGS in PJP with conventional methods, including Gomori methenamine silver staining and serum (1,3)-β-d-glucan. Modifications of antimicrobial treatment for PJP patients after the report of mNGS results were also reviewed. RESULTS: mNGS reached a sensitivity of 100% in diagnosing PJP, which was remarkably higher than Gomori methenamine silver staining (25.0%) and serum (1,3)-β-d-glucan (67.4%). The specificity of mNGS (96.3%) significantly surpassed serum (1,3)-β-d-glucan (81.4%). Simultaneous mNGS of bronchoalveolar lavage fluid and blood samples was performed in 21 out of 60 PJP patients, and it showed a concordance rate of 100% in detecting P. jirovecii. Besides, mNGS showed good performance in identifying co-pathogens of PJP patients, among which cytomegalovirus and Epstein-Barr virus were most commonly seen. Initial antimicrobial treatment was modified in 71.7% of PJP patients after the report of mNGS results. CONCLUSION: mNGS is a useful diagnostic tool with good performance for the diagnosis of PJP and the detection of co-pathogens. mNGS of bronchoalveolar lavage fluid and/or blood samples is suggested in patients with presumptive diagnosis of PJP. Blood samples may be a good alternative to bronchoalveolar lavage fluid for mNGS when bronchoscopic examination is not feasible.
format Online
Article
Text
id pubmed-8322252
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-83222522021-08-19 Metagenomic Next-Generation Sequencing for the Diagnosis of Pneumocystis jirovecii Pneumonia in Non-HIV-Infected Patients: A Retrospective Study Jiang, Juan Bai, Lu Yang, Wei Peng, Wenzhong An, Jian Wu, Yanhao Pan, Pinhua Li, Yuanyuan Infect Dis Ther Original Research INTRODUCTION: This study aimed to evaluate the utility of metagenomic next-generation sequencing (mNGS) for the diagnosis of Pneumocystis jirovecii pneumonia (PJP) in non-human immunodeficiency virus-infected patients. METHODS: We conducted a retrospective study. A total of 60 non-human immunodeficiency virus-infected PJP patients and 134 patients diagnosed with non-PJP pneumonia were included. P. jirovecii and other co-pathogens identified by mNGS in bronchoalveolar lavage fluid and/or blood samples were analyzed. Using clinical composite diagnosis as the reference standard, we compared the diagnostic performance of mNGS in PJP with conventional methods, including Gomori methenamine silver staining and serum (1,3)-β-d-glucan. Modifications of antimicrobial treatment for PJP patients after the report of mNGS results were also reviewed. RESULTS: mNGS reached a sensitivity of 100% in diagnosing PJP, which was remarkably higher than Gomori methenamine silver staining (25.0%) and serum (1,3)-β-d-glucan (67.4%). The specificity of mNGS (96.3%) significantly surpassed serum (1,3)-β-d-glucan (81.4%). Simultaneous mNGS of bronchoalveolar lavage fluid and blood samples was performed in 21 out of 60 PJP patients, and it showed a concordance rate of 100% in detecting P. jirovecii. Besides, mNGS showed good performance in identifying co-pathogens of PJP patients, among which cytomegalovirus and Epstein-Barr virus were most commonly seen. Initial antimicrobial treatment was modified in 71.7% of PJP patients after the report of mNGS results. CONCLUSION: mNGS is a useful diagnostic tool with good performance for the diagnosis of PJP and the detection of co-pathogens. mNGS of bronchoalveolar lavage fluid and/or blood samples is suggested in patients with presumptive diagnosis of PJP. Blood samples may be a good alternative to bronchoalveolar lavage fluid for mNGS when bronchoscopic examination is not feasible. Springer Healthcare 2021-07-10 2021-09 /pmc/articles/PMC8322252/ /pubmed/34244957 http://dx.doi.org/10.1007/s40121-021-00482-y Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Original Research
Jiang, Juan
Bai, Lu
Yang, Wei
Peng, Wenzhong
An, Jian
Wu, Yanhao
Pan, Pinhua
Li, Yuanyuan
Metagenomic Next-Generation Sequencing for the Diagnosis of Pneumocystis jirovecii Pneumonia in Non-HIV-Infected Patients: A Retrospective Study
title Metagenomic Next-Generation Sequencing for the Diagnosis of Pneumocystis jirovecii Pneumonia in Non-HIV-Infected Patients: A Retrospective Study
title_full Metagenomic Next-Generation Sequencing for the Diagnosis of Pneumocystis jirovecii Pneumonia in Non-HIV-Infected Patients: A Retrospective Study
title_fullStr Metagenomic Next-Generation Sequencing for the Diagnosis of Pneumocystis jirovecii Pneumonia in Non-HIV-Infected Patients: A Retrospective Study
title_full_unstemmed Metagenomic Next-Generation Sequencing for the Diagnosis of Pneumocystis jirovecii Pneumonia in Non-HIV-Infected Patients: A Retrospective Study
title_short Metagenomic Next-Generation Sequencing for the Diagnosis of Pneumocystis jirovecii Pneumonia in Non-HIV-Infected Patients: A Retrospective Study
title_sort metagenomic next-generation sequencing for the diagnosis of pneumocystis jirovecii pneumonia in non-hiv-infected patients: a retrospective study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322252/
https://www.ncbi.nlm.nih.gov/pubmed/34244957
http://dx.doi.org/10.1007/s40121-021-00482-y
work_keys_str_mv AT jiangjuan metagenomicnextgenerationsequencingforthediagnosisofpneumocystisjiroveciipneumoniainnonhivinfectedpatientsaretrospectivestudy
AT bailu metagenomicnextgenerationsequencingforthediagnosisofpneumocystisjiroveciipneumoniainnonhivinfectedpatientsaretrospectivestudy
AT yangwei metagenomicnextgenerationsequencingforthediagnosisofpneumocystisjiroveciipneumoniainnonhivinfectedpatientsaretrospectivestudy
AT pengwenzhong metagenomicnextgenerationsequencingforthediagnosisofpneumocystisjiroveciipneumoniainnonhivinfectedpatientsaretrospectivestudy
AT anjian metagenomicnextgenerationsequencingforthediagnosisofpneumocystisjiroveciipneumoniainnonhivinfectedpatientsaretrospectivestudy
AT wuyanhao metagenomicnextgenerationsequencingforthediagnosisofpneumocystisjiroveciipneumoniainnonhivinfectedpatientsaretrospectivestudy
AT panpinhua metagenomicnextgenerationsequencingforthediagnosisofpneumocystisjiroveciipneumoniainnonhivinfectedpatientsaretrospectivestudy
AT liyuanyuan metagenomicnextgenerationsequencingforthediagnosisofpneumocystisjiroveciipneumoniainnonhivinfectedpatientsaretrospectivestudy